Normal plasma antithrombin activity in patients with relapsing–remitting and secondary progressive multiple sclerosis - Campos-de-Magalhães, Marilza; Almeida, Adilson José de; Papaiz-Alvarenga, Regina Maria; Gadelha, Telma; Morais-de-Sá, Carlos Alberto; Alves-Leon, Soniza Vieira (Clinical neurology and neurosurgery, 2009)
Keywords: Adult; Anticoagulants; Antithrombin; Antithrombins - metabolism; Binding sites; Biological and medical sciences; Biomarkers; Coagulation; Confidence intervals; Cytokines; Disability Evaluation; Disease; Drug therapy; Endothelium; Female; Hemostasis; Hospitals; Humans; Inflammation; Male; Medical sciences; Middle Aged; Molecular weight; Multiple sclerosis; Multiple Sclerosis, Chronic Progressive - blood; Multiple Sclerosis, Chronic Progressive - pathology; Neurology; Neurosurgery; Pathogenesis; Plasma; Proteins; Reference Values; Standard deviation; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Thrombin; Thrombin - metabolism; Thrombin; Multiple sclerosis; Inflammation; Hemostasis; Antithrombin; Coagulation; Human; Nervous system diseases; Serine endopeptidases; Enzyme; Inflammatory disease; Peptidases; Surgery; Central nervous system disease; Hydrolases